A clinical trial to study effect of ERAS protocol in improving outcome in patients undergoing surgery for stomach cancer

Not yet recruiting

• Conditions: Malignant neoplasm of stomach, unspecified, (2) ICD-10 Condition: O||Medical and Surgical,

• Registration Number: CTRI/2022/03/041346
• Lead Sponsor: SRIRAM V S

Brief Summary

This is a single centered, randomized control trial studying the effect of Enhanced Recovery After Surgery protocol in patients of gastric cancer undergoing elective gastrectomy. The primary outcome of the study will be length of Hospitalization and secondary outcomes will be occurrence of post operative pulmonary complications, and to compare immunological an inflammatory indices of the two study groups

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-03-18
• Study Start: 2022-04-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

1.Patients admitted for elective gastrectomy procedure in the department of Surgery.

Exclusion Criteria

Age < 18 years or > 75 years ASA (American Society of Anesthesiologists) physical status more than III Conditions that make cooperation with ERAS programme impossible (e.g. Mental disorder, paralysis) Severe organ dysfunction (heart, brain, hepatic or renal) Patients with diabetes who require High insulin therapy for uncontrolled diabetes/ Severe malnutrition Distant metastases necessitating resection of other organs Patients who cannot perform the prescribed respiratory prehabilitation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Length of hospitalization- from the day of admission to the day of discharge	date of admission | date of surgery | date of discharge from hospital
Length of postoperative hospital stay- measured from day of surgery to day of discharge.	date of admission | date of surgery | date of discharge from hospital

Secondary Outcome Measures

Name	Time	Method
1.Serum albumin and prealbumin	2.C reactive protein
Pulmonary complications (atelectasis, pleural effusion)	every 24 hours in the postoperative period and at discharge

Trial Locations

Locations (1)

Jawaharlal Institute of Postgraduate Medical Education and Research; 🇮🇳 Pondicherry, PONDICHERRY, India

Jawaharlal Institute of Postgraduate Medical Education and Research

🇮🇳Pondicherry, PONDICHERRY, India

Dr Suresh Kumar

Principal investigator

9788637893

Drsureshkumar08@gmail.com